Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model

Journal of Surgical Oncology

Volumn 78, Issue 1, 2001, Pages 22-29

  Moroz, Paul ^a   Jones, Stephen K ^b   Winter, Jillean ^b   Gray, Bruce N ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Sirtex Medical Limited   (Australia)

Author keywords

Hepatic arterial infusion; Lipiodol; Liver cancer; Magnetic particles

Indexed keywords

FERROMAGNETIC MATERIAL; IODINATED POPPYSEED OIL; IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; CANCER THERAPY; DRUG DELIVERY SYSTEM; HEATING; HYPERTHERMIC THERAPY; LIVER TUMOR; MAGNETIC FIELD; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; EMBOLIZATION, THERAPEUTIC; FERRIC COMPOUNDS; HEPATIC ARTERY; HYPERTHERMIA, INDUCED; INFUSIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS, EXPERIMENTAL; RABBITS;

EID: 0034874515     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.1118     Document Type: Article

References (51)

1. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
2. Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system
3. Resection of colorectal liver metastases
4. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases
5. Resection of colorectal liver metastases: 25 Year experience
6. Hepatic resection for colorectal metastases: Analysis of prognostic factors
7. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin
8. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases
9. Prognostic factors following liver resection for hepatic metastases from colorectal cancer
10. A study of prognostic factors for hepatic resection for colorectal metastases
11. Late results justify resection for multiple hepatic metastases from colorectal cancer
12. Patient selection for hepatic resection of colorectal metastases
13. Determinants of survival following hepatic resection for metastatic colorectal cancer
14. Resection of liver metastases of colorectal carcinoma
15. Surgical margin in hepatic resection for colorectal metastases: A critical and improvable determinant of outcome
16. Ninety six five year survivors after liver resection for metastatic colorectal cancer
17. Liver resection for colorectal metastases
18. Benefits and safety of hepatic resection for colorectal metastases
19. Surgical management of hepatocellular carcinoma
20. Locoregional treatments of unresectable liver metastases from colorectal cancer
21. Hepatic arterial infusion chemotherapy for colorectal cancer metastasis to the liver
22. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment
23. Distribution of different sized microspheres in experimental hepatic tumors
24. Ultrasonography in hepatobiliary and pancreatic malignancies
25. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
26. The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment
27. Arrhenius relationships from the molecule and cell to the clinic
28. Magnetic fluid hyperthermia
29. Hyperthermia in cancer therapy: Where are we today and where are we going?
30. The treatment of malignancy by hyperthermia
31. The current and potential role of hyperthermia in radiotherapy
32. Hyperthermia and drugs
33. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies
34. Internal radiotherapy for hepatic metastases; the blood supply of hepatic metastases
35. The vascularization of small liver metastases
36. Comparison of portal vein chemotherapy with hepatic arterial chemotherapy in the treatment of liver micrometastases
37. The blood supply of neoplasms in the liver
38. Biodistribution and in vivo kinetics of iodine 131 lipiodol infused via the hepatic artery of patients with hepatic cancer
39. Distribution of lipiodol in hepatocellular carcinoma
40. Human liver cells and endothelial cells incorporate iodised oil
41. Treatment of small hepatocellular carcinoma
42. Selective and persistent deposition and gradual drainage of iodised oil, Lipiodol in hepatocellular carcinoma after injection into the feeding hepatic artery
43. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents
44. Distribution of different sized microspheres in experimental hepatic tumors
45. Targeted hyperthermia using dextran magnetite complex: A new treatment modality for liver tumors
46. Measurement of the Neel relaxation of magnetic particles in the frequency range 1 kHz to 160 MHz
47. Tumour regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite incorporated microspheres in rats